The WA company behind an imaging device which can reduce the number of repeat surgeries for breast cancer patients has received $27 million in a private funding round to support its push to US FDA approval.

The WA company behind an imaging device which can reduce the number of repeat surgeries for breast cancer patients has received $27 million in a private funding round to support its push to US FDA approval.